수술용 레이저 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the surgical laser market size is expected to grow from USD 9.22 billion in 2025 to USD 10.26 billion in 2026 and is forecast to reach USD 17.48 billion by 2031 at 11.25% CAGR over 2026-2031.

This report Segments the Industry Into Laser Type (Carbon Dioxide (CO2) Lasers, Nd:yag Lasers, and More), Procedure (Open Surgery, Laparoscopic Surgery, and More), Application (Dermatology, Ophthalmology, Urology, and More), End User (Hospitals, Ambulatory Surgical Centres, and More), and Geography. The Market Sizes and Forecasts are Provided in Terms of Value (USD).

Global Surgical Lasers Market Trends and Insights

Technological Advancements in Beam-Shaping Optics

Liquid-lens modules now correct focal drift inside flexible fibers, enabling steady ablation at depths past 700 µm-more than triple previous limits . Fiber shapers developed at MIT tailor beam patterns that cut scattering by half and preserve native tissue architecture, which is crucial for intra-operative imaging. When paired with optical coherence tomography, surgeons receive real-time cross-sections that guide submillimeter resections. Efficiency gains also reduce average pulse energy, lowering thermal damage margins. Collectively, these advances enhance patient safety and shrink operative time, giving the surgical laser market a measurable quality edge that hospitals can monetize through faster case turnover.

Preference for Minimally-Invasive & Day-Care Surgeries

Ambulatory facilities now perform a majority of cataract and gall-bladder cases under local anesthesia, encouraged by a 2025 CMS rule that raises ASC payments by 2.6%. Patients benefit from same-day discharge and 20% shorter wait lists, while payers save up to 45% on facility fees, reinforcing a volume shift into the surgical laser market. Laser platforms with plume-capture and quick-swap fiber handpieces fit ASC workflows and minimize room turnaround time. As outpatient centers invest in robotic carts that combine endoscopy and laser cutting, procedure complexity gradually rises without eroding cost efficiency.

High Capital & Procedural Costs

State-of-the-art femtosecond workstations can exceed USD 500,000, a hurdle for smaller clinics whose reimbursements remain technique-agnostic. Cost-utility studies confirm visual gains but note payback periods beyond five years in low-volume settings. Mandatory laser safety officer training and ventilation upgrades add overhead. Where humanitarian cataract missions operate at USD 276 per eye, capital intensity underscores adoption gaps . Price sensitivity in emerging economies dampens unit sales and tempers the global surgical laser market trajectory.

Other drivers and restraints analyzed in the detailed report include:

1. Rising Incidence of Ophthalmic & Urologic Disorders
2. Regulatory Approvals Expanding Clinical Indications
3. Reimbursement Gaps in Emerging Economies

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Carbon dioxide systems held 34.18% of 2025 revenue, owing to their reliability in ENT and gynecology. At USD 10.26 billion, the surgical laser market size continues to rely on CO2 for precise vaporization with minimal bleeding. Yet diode units, projected to expand at 12.18% CAGR, are eroding entry-level CO2 share as 445 nm wavelengths cut soft tissue efficiently while consuming less power. Manufacturers emphasize portable chassis and lower consumable costs, aligning with ASC budgets. As photonic-crystal fibers mature, diode beam quality improves, allowing ENT surgeons to achieve 1 mm cut depths with limited collateral heat. The trend suggests incremental but persistent diversification, safeguarding supply chains from helium scarcity that threatens glass-tube CO2 capacity.

Carbon dioxide suppliers counter with hybrid systems that embed mid-infrared modules to expand dermatology and oncology use cases. Excimer platforms remain irreplaceable for corneal reshaping and now incorporate active-eye tracking to compensate for micro-saccades, boosting outcome predictability. Fiber and Er:YAG designs pair with robots for spine decompression, reflecting a strategy to widen the surgical laser market by tying hardware to procedure-specific software.

Open surgery retained 32.30% of 2025 procedures as legacy protocols and surgeon familiarity persist. Nonetheless, robot-assisted cases are climbing at 12.36% CAGR and already represent a quarter of prostatectomies in leading U.S. centers. Force-feedback sensors integrated into laser end-effectors trim tissue damage by 43%, supporting surgeon confidence. As software updates roll out remotely, installed robots gain new laser modalities without hardware swaps, pushing the surgical laser market toward service-based revenue.

Laparoscopic laser adoption grows steadily, bolstered by high-resolution imaging and plume suction filters that preserve visibility. Percutaneous lithotripsy benefits from thulium-fiber efficiency, shortening operative times and lowering anesthesia exposure. Together, these shifts point to a surgical suite where lasers, robots and imaging platforms operate as a single digital ecosystem, raising entry barriers for newcomers.

Complete Report Scope:

• By Laser Type
  • Carbon Dioxide (CO2) Lasers
  • Nd:YAG Lasers
  • Diode Lasers
  • Holmium:YAG Lasers
  • Fiber & Er:YAG Lasers
  • Excimer Lasers
  • Other Lasers
• By Procedure
  • Open Surgery
  • Laparoscopic Surgery
  • Percutaneous Surgery
  • Robot-assisted Surgery
• By Application
  • Dermatology
  • Ophthalmology
  • Urology
  • Dentistry
  • Gynecology
  • Cardiology
  • Gastroenterology
  • Oncology
  • Other Applications
• By End User
  • Hospitals
  • Ambulatory Surgical Centres
  • Specialty & Aesthetic Clinics
  • Other End Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East
    • GCC
    • South Africa
    • Rest of Middle East
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America generated 44.72% of 2025 revenue on the back of early technology adoption, favorable payer policies and a dense ASC network. FDA approvals of the da Vinci 5 robot and TENEO excimer laser set clinical precedents and underpin replacement cycles. Large device firms report double-digit U.S. revenue gains as hospitals refresh fleets to comply with Laser Notice No. 56. Persistent helium cost inflation, however, nudges providers toward fiber-based alternatives, illustrating a regional pivot that influences global supply strategies.

Asia-Pacific is poised for 12.89% CAGR through 2031. Public insurance expansion in China has spurred double-digit growth in robotic-laser procedures, and Japan's 97.3% success rate in office-based vitreoretinal work validates outpatient complex surgery. India's urban hospital chains invest in multi-specialty lasers even as reimbursement lag restrains rural penetration. Government-funded cancer centers in South Korea and Singapore are installing dual-wavelength suites, signaling sustained investment momentum within the surgical laser market.

Europe shows balanced progress. Harmonization with IEC standards simplifies cross-border trade, and energy-efficient fiber lasers align with the region's sustainability regulations, consuming roughly one-third of the electricity of legacy CO2 models. Eastern European nations leverage EU structural funds to modernize ORs, though reimbursement ceilings temper high-end adoption. The Middle East and South America represent emerging corridors, where medical tourism and private hospital groups drive premium equipment purchases, yet currency volatility and spot helium shortages present operational hurdles.

1. Lumenis
2. Boston Scientific
3. IPG Photonics
4. Cynosure
5. Alma Lasers
6. Biolitec
7. Fotona
8. Candela Medical
9. Cutera
10. BIOLASE
11. Alcon
12. Abbott Laboratories
13. Iridex
14. BISON Medical
15. Spectranetics (Philips)
16. El.En. SpA
17. Quanta System
18. Gigaalaser
19. OmniGuide
20. Asclepion Laser Technologies

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Technological advancements in beam-shaping optics
  • 4.2.2 Preference for minimally-invasive & day-care surgeries
  • 4.2.3 Rising incidence of ophthalmic & urologic disorders
  • 4.2.4 Regulatory approvals expanding clinical indications
  • 4.2.5 Rapid adoption of outpatient laser suites (ASC model)
  • 4.2.6 AI-driven real-time laser dosimetry & workflow gains
• 4.3 Market Restraints
  • 4.3.1 High capital & procedural costs
  • 4.3.2 Reimbursement gaps in emerging economies
  • 4.3.3 Global helium shortage disrupting CO2-tube supply
  • 4.3.4 Tighter plume-safety rules inflating compliance spend
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value)

• 5.1 By Laser Type
  • 5.1.1 Carbon Dioxide (CO2) Lasers
  • 5.1.2 Nd:YAG Lasers
  • 5.1.3 Diode Lasers
  • 5.1.4 Holmium:YAG Lasers
  • 5.1.5 Fiber & Er:YAG Lasers
  • 5.1.6 Excimer Lasers
  • 5.1.7 Other Lasers
• 5.2 By Procedure
  • 5.2.1 Open Surgery
  • 5.2.2 Laparoscopic Surgery
  • 5.2.3 Percutaneous Surgery
  • 5.2.4 Robot-assisted Surgery
• 5.3 By Application
  • 5.3.1 Dermatology
  • 5.3.2 Ophthalmology
  • 5.3.3 Urology
  • 5.3.4 Dentistry
  • 5.3.5 Gynecology
  • 5.3.6 Cardiology
  • 5.3.7 Gastroenterology
  • 5.3.8 Oncology
  • 5.3.9 Other Applications
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Ambulatory Surgical Centres
  • 5.4.3 Specialty & Aesthetic Clinics
  • 5.4.4 Other End Users
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Lumenis
  • 6.3.2 Boston Scientific
  • 6.3.3 IPG Photonics
  • 6.3.4 Cynosure
  • 6.3.5 Alma Lasers
  • 6.3.6 biolitec AG
  • 6.3.7 Fotona
  • 6.3.8 Candela Medical
  • 6.3.9 Cutera
  • 6.3.10 Biolase
  • 6.3.11 Alcon
  • 6.3.12 Abbott Laboratories
  • 6.3.13 IRIDEX Corp.
  • 6.3.14 BISON Medical
  • 6.3.15 Spectranetics (Philips)
  • 6.3.16 El.En. SpA
  • 6.3.17 Quanta System
  • 6.3.18 Gigaalaser
  • 6.3.19 OmniGuide
  • 6.3.20 Asclepion Laser Technologies

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment